Buprenorphine May Lower Birth Risks More Than Methadone

For pregnant patients in treatment for opioid use disorder, a new research review puts two standard medications side by side and finds the choice may affect newborn health.

Comparing methadone and buprenorphine in pregnancy, the analysis found buprenorphine was linked to a lower risk of several adverse birth outcomes, according to a systematic review and meta-analysis published in BMC Pregnancy and Childbirth.

Both medications are considered safe and are widely used in opioid treatment. What the review adds is a direct comparison during pregnancy, a question the authors note had not been well settled.

How Buprenorphine and Methadone Compare

Researchers pooled 27 studies covering 14,978 pregnancies exposed to buprenorphine and 8,358 exposed to methadone.

In the combined observational data, buprenorphine versus methadone was associated with a lower risk of preterm birth, low birthweight, small size for gestational age and the need to treat neonatal opioid withdrawal syndrome.

On two measures the medications looked similar: the review found no difference between them in withdrawal diagnosis or in stillbirth, which was rare.

So the comparison is not a clean win on every front. It points to buprenorphine carrying lower risk on several newborn outcomes while looking comparable to methadone on others.

Why the Evidence Is Not the Final Word

The authors are careful about how far these findings reach. The pooled analyses were unadjusted, the studies varied widely, and some samples were small, so the results show an association rather than proof that one medication causes better outcomes.

Methadone treatment remains an effective, appropriate choice for many patients, and nothing in the review suggests otherwise.

Why Medical Detox Matters in Pregnancy

Managing opioid dependence during pregnancy is not something to attempt alone. Withdrawal can be dangerous for both patient and pregnancy, which is why medication-assisted treatment under medical supervision is the recommended approach rather than abrupt cessation or unsupervised medical detox.

Understanding Buprenorphine and Methadone

Both medications are forms of medication-assisted treatment for opioid use disorder. Methadone is a full opioid agonist, while buprenorphine is a partial agonist often combined with naloxone.

Each eases withdrawal symptoms and reduces cravings, allowing patients to stabilize and stay in care. The right choice depends on the individual, and this comparison may inform that conversation without dictating it.

What This Means for Expecting Patients

Anyone pregnant and undergoing addiction treatment for opioid use disorder should work closely with both an obstetric provider and an addiction specialist before starting, switching or stopping any medication.

This research may give clinicians and patients one more data point to weigh together, but the decision between buprenorphine and methadone remains individual.

Finding Medical Detox

Never attempt opioid detox during pregnancy without medical supervision. Detox.com’s directory of detox centers can help you locate medically supervised programs and medication-assisted treatment providers experienced with pregnancy.

You can can start care in a safe, monitored setting. Call 800-996-6135(Sponsored) to connect with a treatment advisor today.